+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oligonucleotide Synthesis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 159 Pages
  • January 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5934411

Custom Oligonucleotide Segment Leads with Strong Market Share and Robust Growth Prospects

Oligonucleotides, short fragments of nucleic acids, are witnessing a significant surge in demand as they play a pivotal role in laboratories for various applications including therapeutics, diagnostics, academic research, and industrial processes. These molecules, synthesized through a combination of genetic engineering and enzyme chemistry, have become indispensable in the realms of initial research, target validation, and drug production.

Oligonucleotide synthesis can occur either through commercial services catering to a wide range of end users or through individual synthesis using DNA synthesizers. Recent advancements in synthesis techniques, amplification methods, and automation have revolutionized biological research, offering researchers the ability to customize and obtain specific sequences conveniently and promptly. These services vary in terms of cost per base pair, error rates, lengths, and throughput, among other factors.

Market Analysis Highlights:

According to market analysis, the custom oligonucleotide synthesis segment is expected to lead the market with a higher market share compared to the universal oligonucleotide synthesis segment. The custom oligonucleotide segment is projected to reach a market size of over US$540 million by the end of 2025. Meanwhile, the universal oligonucleotide synthesis segment is anticipated to expand at a CAGR of 7.8% during the forecast period from 2024 to 2031.

In light of these growth prospects, companies are intensifying their focus on improving services through technological enhancements, enabling high-throughput synthesis while maintaining cost-effectiveness to capture maximum market share.

Key Drivers of the Oligonucleotide Synthesis Market:

The global market for custom oligonucleotide synthesis is experiencing rapid growth, fueled by the increasing pace of research and development in synthetic biology. The industry's demand for high-end customized oligos is on the rise, particularly as synthetic oligonucleotides find applications in various industrial and academic research labs. This surge in demand is driving efforts to enhance quality by reducing impurities and increasing effectiveness.

Challenges posed by the cost of purification, which accounts for approximately 50% of total production costs, are prompting ongoing research to identify improved methods for achieving desired results. Innovative non-chromatographic purification methods and in-house modifications are among the avenues explored to overcome this hurdle.

Market Dynamics:

The global oligonucleotide synthesis market is currently characterized by established players in both equipment and services, boasting strong brand recognition and extensive distribution channels. These systematic distribution networks have contributed to the market's upward trajectory.

However, a noteworthy trend has emerged with the in-house development of oligonucleotides, primarily driven by academic and research institutes. Some biopharmaceutical companies have also opted to develop oligonucleotides in-house or outsource the manufacturing process to maintain confidentiality and streamline production. This trend, although beneficial for cost efficiency, may impact sales from service providers and potentially narrow the market scope.

Challenges in the Oligonucleotide Synthesis Market:

Despite the promising growth outlook, the global oligonucleotide synthesis market faces certain challenges. In-house development by academic and research institutes, coupled with cost constraints, could restrict the market's scope. Additionally, limitations in available resources, including funding for research in academic laboratories and a shortage of skilled personnel, may hinder research activities and, consequently, the market's growth.

Market Segmentation

By Service Type

  • Universal Oligonucleotide Synthesis
  • Custom Oligonucleotide Synthesis

By Application

  • Academic R&D
  • Commercial R&D

By End Users

  • Biopharmaceutical Companies
  • Academic & Research Institutes
  • Contract Research Organizations

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Oligonucleotide Synthesis Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Oligonucleotide Synthesis Market Outlook, 2018 - 2031
3.1. Global Oligonucleotide Synthesis Market Outlook, by Service Type, Value (US$ Mn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Universal Oligonucleotide Synthesis
3.1.1.2. Custom Oligonucleotide Synthesis
3.2. Global Oligonucleotide Synthesis Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Academic R&D
3.2.1.2. Commercial R&D
3.3. Global Oligonucleotide Synthesis Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Biopharmaceutical Companies
3.3.1.2. Academic & Research Institutes
3.3.1.3. Contract Research Organizations
3.4. Global Oligonucleotide Synthesis Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Oligonucleotide Synthesis Market Outlook, 2018 - 2031
4.1. North America Oligonucleotide Synthesis Market Outlook, by Service Type, Value (US$ Mn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Universal Oligonucleotide Synthesis
4.1.1.2. Custom Oligonucleotide Synthesis
4.2. North America Oligonucleotide Synthesis Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Academic R&D
4.2.1.2. Commercial R&D
4.3. North America Oligonucleotide Synthesis Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Biopharmaceutical Companies
4.3.1.2. Academic & Research Institutes
4.3.1.2.1. Contract Research Organizations
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Oligonucleotide Synthesis Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. U.S. Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
4.4.1.2. U.S. Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
4.4.1.3. U.S. Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
4.4.1.4. Canada Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
4.4.1.5. Canada Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
4.4.1.6. Canada Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Oligonucleotide Synthesis Market Outlook, 2018 - 2031
5.1. Europe Oligonucleotide Synthesis Market Outlook, by Service Type, Value (US$ Mn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Universal Oligonucleotide Synthesis
5.1.1.2. Custom Oligonucleotide Synthesis
5.2. Europe Oligonucleotide Synthesis Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Academic R&D
5.2.1.2. Commercial R&D
5.3. Europe Oligonucleotide Synthesis Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Biopharmaceutical Companies
5.3.1.2. Academic & Research Institutes
5.3.2. Contract Research Organizations
5.4. Europe Oligonucleotide Synthesis Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Germany Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
5.4.1.2. Germany Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
5.4.1.3. Germany Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
5.4.1.4. U.K. Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
5.4.1.5. U.K. Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
5.4.1.6. U.K. Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
5.4.1.7. France Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
5.4.1.8. France Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
5.4.1.9. France Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
5.4.1.10. Italy Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
5.4.1.11. Italy Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
5.4.1.12. Italy Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
5.4.1.13. Turkey Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
5.4.1.14. Turkey Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
5.4.1.15. Turkey Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
5.4.1.16. Russia Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
5.4.1.17. Russia Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
5.4.1.18. Russia Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
5.4.1.19. Rest of Europe Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
5.4.1.20. Rest of Europe Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
5.4.1.21. Rest of Europe Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Oligonucleotide Synthesis Market Outlook, 2018 - 2031
6.1. Asia Pacific Oligonucleotide Synthesis Market Outlook, by Service Type, Value (US$ Mn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Universal Oligonucleotide Synthesis
6.1.1.2. Custom Oligonucleotide Synthesis
6.2. Asia Pacific Oligonucleotide Synthesis Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Academic R&D
6.2.1.2. Commercial R&D
6.3. Asia Pacific Oligonucleotide Synthesis Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Biopharmaceutical Companies
6.3.1.2. Academic & Research Institutes
6.3.1.2.1. Contract Research Organizations
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Oligonucleotide Synthesis Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. China Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
6.4.1.2. China Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
6.4.1.3. China Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
6.4.1.4. Japan Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
6.4.1.5. Japan Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
6.4.1.6. Japan Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
6.4.1.7. South Korea Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
6.4.1.8. South Korea Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
6.4.1.9. South Korea Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
6.4.1.10. India Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
6.4.1.11. India Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
6.4.1.12. India Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
6.4.1.13. Southeast Asia Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
6.4.1.14. Southeast Asia Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
6.4.1.15. Southeast Asia Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
6.4.1.16. Rest of Asia Pacific Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
6.4.1.17. Rest of Asia Pacific Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
6.4.1.18. Rest of Asia Pacific Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Oligonucleotide Synthesis Market Outlook, 2018 - 2031
7.1. Latin America Oligonucleotide Synthesis Market Outlook, by Service Type, Value (US$ Mn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Universal Oligonucleotide Synthesis
7.1.1.2. Custom Oligonucleotide Synthesis
7.2. Latin America Oligonucleotide Synthesis Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Academic R&D
7.2.1.2. Commercial R&D
7.3. Latin America Oligonucleotide Synthesis Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Biopharmaceutical Companies
7.3.1.2. Academic & Research Institutes
7.3.1.2.1. Contract Research Organizations
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Oligonucleotide Synthesis Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Brazil Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
7.4.1.2. Brazil Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
7.4.1.3. Brazil Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
7.4.1.4. Mexico Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
7.4.1.5. Mexico Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
7.4.1.6. Mexico Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
7.4.1.7. Argentina Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
7.4.1.8. Argentina Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
7.4.1.9. Argentina Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
7.4.1.10. Rest of Latin America Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
7.4.1.11. Rest of Latin America Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
7.4.1.12. Rest of Latin America Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Oligonucleotide Synthesis Market Outlook, 2018 - 2031
8.1. Middle East & Africa Oligonucleotide Synthesis Market Outlook, by Service Type, Value (US$ Mn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Universal Oligonucleotide Synthesis
8.1.1.2. Custom Oligonucleotide Synthesis
8.2. Middle East & Africa Oligonucleotide Synthesis Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Academic R&D
8.2.1.2. Commercial R&D
8.3. Middle East & Africa Oligonucleotide Synthesis Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Biopharmaceutical Companies
8.3.1.2. Academic & Research Institutes
8.3.1.2.1. Contract Research Organizations
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Oligonucleotide Synthesis Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. GCC Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
8.4.1.2. GCC Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
8.4.1.3. GCC Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
8.4.1.4. South Africa Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
8.4.1.5. South Africa Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
8.4.1.6. South Africa Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
8.4.1.7. Egypt Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
8.4.1.8. Egypt Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
8.4.1.9. Egypt Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
8.4.1.10. Nigeria Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
8.4.1.11. Nigeria Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
8.4.1.12. Nigeria Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
8.4.1.13. Rest of Middle East & Africa Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
8.4.1.14. Rest of Middle East & Africa Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
8.4.1.15. Rest of Middle East & Africa Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By End User vs By Application Heat map
9.2. Manufacturer vs by Application Heatmap
9.3. Company Market Share Analysis, 2022
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Integrated DNA Technologies, Inc.
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. GenScript Biotech Corporation
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Eurofins Scientific SE
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Bioneer Corporation
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Kaneka Corporation (Eurogentec)
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Biolegio B.V.
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Eton Bioscience, Inc.
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. IBA GmbH
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Quintara Biosciences
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. LGC Biosearch Technologies
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. Thermo Fisher Scientific, Inc.
9.5.11.1. Company Overview
9.5.11.2. Product Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development
9.5.12. TriLink BioTechnologies, LLC
9.5.12.1. Company Overview
9.5.12.2. Product Portfolio
9.5.12.3. Financial Overview
9.5.12.4. Business Strategies and Development
9.5.13. TAG Copenhagen A/S
9.5.13.1. Company Overview
9.5.13.2. Product Portfolio
9.5.13.3. Financial Overview
9.5.13.4. Business Strategies and Development
9.5.14. PolyGen GmbH
9.5.14.1. Company Overview
9.5.14.2. Product Portfolio
9.5.14.3. Financial Overview
9.5.14.4. Business Strategies and Development
9.5.15. General Electric Co
9.5.15.1. Company Overview
9.5.15.2. Product Portfolio
9.5.15.3. Financial Overview
9.5.15.4. Business Strategies and Development
9.5.16. BioAutomation
9.5.16.1. Company Overview
9.5.16.2. Product Portfolio
9.5.16.3. Financial Overview
9.5.16.4. Business Strategies and Development
9.5.17. Biolytic Lab Performance Inc.
9.5.17.1. Company Overview
9.5.17.2. Product Portfolio
9.5.17.3. Financial Overview
9.5.17.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Integrated DNA Technologies, Inc.
  • GenScript Biotech Corporation
  • Eurofins Scientific SE
  • Bioneer Corporation
  • Kaneka Corporation (Eurogentec)
  • Biolegio B.V.
  • Eton Bioscience, Inc.
  • IBA GmbH
  • Quintara Biosciences
  • LGC Biosearch Technologies
  • Thermo Fisher Scientific, Inc.
  • TriLink BioTechnologies, LLC
  • TAG Copenhagen A/S
  • PolyGen GmbH
  • General Electric Co
  • BioAutomation
  • Biolytic Lab Performance Inc.

Methodology

Loading
LOADING...